BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1980493)

  • 1. Increase in the level of P-glycoprotein mRNA expression in multidrug-resistant K562 cell lines treated with sodium butyrate is not accompanied with erythroid differentiation.
    Shibata H; Kanamaru R; Sato T; Ishioka C; Konishi Y; Ishikawa A; Wakui A; Tsuruo T
    Jpn J Cancer Res; 1990 Dec; 81(12):1214-7. PubMed ID: 1980493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inducers of erythroid differentiation of human leukemia K562 cells on vincristine-resistant K562/VCR cells.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M; Tsuruo T
    Leuk Res; 1983; 7(4):481-5. PubMed ID: 6684716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents.
    Mickley LA; Bates SE; Richert ND; Currier S; Tanaka S; Foss F; Rosen N; Fojo AT
    J Biol Chem; 1989 Oct; 264(30):18031-40. PubMed ID: 2572588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by erythroid differentiation factor (activin A) of P-glycoprotein expression in multidrug-resistant human K562 erythroleukemia cells.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M; Tsuruo T
    Cancer Res; 1991 May; 51(10):2582-6. PubMed ID: 1673636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro.
    Mizuno K; Furuhashi Y; Maeda O; Iwata M; Misawa T; Kawai M; Kano T; Tomoda Y
    Cancer Chemother Pharmacol; 1990; 26(5):333-9. PubMed ID: 1976451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable effects of sodium butyrate on the expression and function of the MDR1 (P-glycoprotein) gene in colon carcinoma cell lines.
    Frommel TO; Coon JS; Tsuruo T; Roninson IB
    Int J Cancer; 1993 Sep; 55(2):297-302. PubMed ID: 8103760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.
    Hait WN; Choudhury S; Srimatkandada S; Murren JR
    J Clin Invest; 1993 May; 91(5):2207-15. PubMed ID: 8098047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
    Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells.
    Kitazono M; Sumizawa T; Takebayashi Y; Chen ZS; Furukawa T; Nagayama S; Tani A; Takao S; Aikou T; Akiyama S
    J Natl Cancer Inst; 1999 Oct; 91(19):1647-53. PubMed ID: 10511592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance in response to differentiation in the K562 human leukaemia cell line.
    Marks DC; Davey MW; Davey RA; Kidman AD
    Biochem Pharmacol; 1995 Aug; 50(4):475-80. PubMed ID: 7646552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate.
    Bates SE; Currier SJ; Alvarez M; Fojo AT
    Biochemistry; 1992 Jul; 31(28):6366-72. PubMed ID: 1352990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance of human multidrug-resistant cells to mitomycin C.
    Yusa K; Sato W; Yamazaki A; Tsukahara S; Tsuruo T
    Anticancer Res; 1991; 11(3):1301-4. PubMed ID: 1909515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.
    Bates SE; Mickley LA; Chen YN; Richert N; Rudick J; Biedler JL; Fojo AT
    Mol Cell Biol; 1989 Oct; 9(10):4337-44. PubMed ID: 2573830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of adriamycin-resistant and radiation-sensitive Chinese hamster cell lines.
    Sognier MA; Zhang Y; Eberle RL; Belli JA
    Biochem Pharmacol; 1992 Nov; 44(9):1859-68. PubMed ID: 1360213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycin.
    Lee WP; Lee CL; Kao MC
    Biochem Biophys Res Commun; 1992 Nov; 189(1):92-100. PubMed ID: 1360209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
    Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J
    Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p-glycoprotein in multidrug-resistant human leukemia k562 cells during erythroid-differentiation.
    Fardel O; Escande F; Rault B; Drenou B; Lebescot J; Fauchet R
    Int J Oncol; 1995 Aug; 7(2):377-81. PubMed ID: 21552851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles.
    Gekeler V; Weger S; Probst H
    Biochem Biophys Res Commun; 1990 Jun; 169(2):796-802. PubMed ID: 1972623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of P-glycoprotein mRNA in human gastric tumors.
    Sugimoto Y; Asami N; Tsuruo T
    Jpn J Cancer Res; 1989 Oct; 80(10):993-9. PubMed ID: 2575610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.
    Takeda Y; Nishio K; Sugimoto Y; Kasahara K; Kubo S; Fujiwara Y; Niitani H; Saijo N
    Int J Cancer; 1991 Jul; 48(6):931-7. PubMed ID: 1677641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.